Henry A. Fernandez, Director at Royalty Pharma plc (RPRX), bought 32,500 shares at $37.49 ($1.2M) on 2022-02-24, disclosed to the SEC on 2022-02-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| MSCI | BUY | 2025-12-09 | $13.3M | — | Filing → |
| MSCI | BUY | 2025-07-28 | $12.1M | — | Filing → |
| MSCI | BUY | 2025-02-25 | $3.0M | — | Filing → |